Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment
- PMID: 31304808
- DOI: 10.1080/14740338.2019.1644317
Metabolic complications affecting adipose tissue, lipid and glucose metabolism associated with HIV antiretroviral treatment
Abstract
Introduction: Efficient antiretroviral-treatment (ART) generally allows control of HIV infection. However, persons-living-with-HIV (PLWH), when aging, present a high prevalence of metabolic diseases. Area covered: Altered adiposity, dyslipidemias, insulin resistance, diabetes, and their consequences are prevalent in PLWH and could be partly related to ART. Expert opinion: At first, personal and lifestyle factors are involved in the onset of these complications. The persistence of HIV in tissue reservoirs could synergize with some ART and enhance metabolic disorders. Altered fat repartition, diagnosed as lipodystrophy, has been related to first-generation nucleoside-reverse-transcriptase-inhibitors (NRTIs) (stavudine zidovudine) and some protease inhibitors (PIs). Recently, use of some integrase-inhibitors (INSTI) resulted in weight/fat gain, which represents a worrisome unresolved situation. Lipid parameters were affected by some first-generation NRTIs, non-NRTIs (efavirenz) but also PIs boosted by ritonavir, with increased total and LDL-cholesterol and triglycerides. Insulin resistance is common associated with abdominal obesity. Diabetes incidence, high with first-generation-ART (zidovudine, stavudine, didanosine, indinavir) has declined with contemporary ART close to that of the general population. Metabolic syndrome, a dysmetabolic situation with central obesity and insulin resistance, and liver steatosis are common in PLWH and could indirectly result from ART-associated fat gain and insulin resistance. All these dysmetabolic situations increase the atherogenic cardiovascular risk.
Keywords: Adipose tissue; HIV; antiretroviral treatment; diabetes; dyslipidemia; insulin resistance; integrase inhibitors; non-nucleoside analogues reverse transcriptase inhibitors; nucleoside analogues reverse transcriptase inhibitors; protease inhibitors; steatosis.
Similar articles
-
[Lipid disorders in patients with HIV-induced diseases].Presse Med. 2005 Sep 10;34(15):1087-94. doi: 10.1016/s0755-4982(05)84124-7. Presse Med. 2005. PMID: 16334888 Review. French.
-
Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors.AIDS Rev. 2015 Jan-Mar;17(1):21-36. AIDS Rev. 2015. PMID: 25472015
-
HIV and adipose tissue: A long history linked to therapeutic classes of antiretrovirals.Ann Endocrinol (Paris). 2024 Jun;85(3):255-258. doi: 10.1016/j.ando.2024.05.005. Epub 2024 Jun 12. Ann Endocrinol (Paris). 2024. PMID: 38871510 Review.
-
[Metabolic side effects of antiretroviral therapy].Ned Tijdschr Geneeskd. 2008 May 31;152(22):1260-4. Ned Tijdschr Geneeskd. 2008. PMID: 18590059 Review. Dutch.
-
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.HIV Med. 2005 Nov;6(6):396-402. doi: 10.1111/j.1468-1293.2005.00325.x. HIV Med. 2005. PMID: 16268821
Cited by
-
The relationship between HIV/AIDS and coronary heart disease: A bibliometric analysis.Medicine (Baltimore). 2024 Oct 4;103(40):e39831. doi: 10.1097/MD.0000000000039831. Medicine (Baltimore). 2024. PMID: 39465717 Free PMC article.
-
Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review.Infect Dis Rep. 2024 Sep 1;16(5):846-863. doi: 10.3390/idr16050066. Infect Dis Rep. 2024. PMID: 39311207 Free PMC article. Review.
-
Impact of Combination Antiretroviral Treatment on Liver Metabolic Health in HIV-Infected Persons.Viruses. 2023 Dec 15;15(12):2432. doi: 10.3390/v15122432. Viruses. 2023. PMID: 38140673 Free PMC article. Review.
-
Evaluating the use of antiviral drugs in HIV patients with cardiovascular diseases and how to reduce the incidence of cardiac events in these patients.Am J Cardiovasc Dis. 2024 Apr 15;14(2):70-80. doi: 10.62347/OBXQ4787. eCollection 2024. Am J Cardiovasc Dis. 2024. PMID: 38764550 Free PMC article. Review.
-
Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients.Biomedicines. 2021 Aug 9;9(8):987. doi: 10.3390/biomedicines9080987. Biomedicines. 2021. PMID: 34440191 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical